HIV and Retroviral Diseases
A retrovirus is a type of virus that belongs to the Retroviridae family that transmits its genetic blueprint in the form of ribonucleic acid (RNA). Retroviruses are called after the reverse transcriptase enzyme, which was discovered by American virologists Howard Temin and David Baltimore in 1971. Reverse transcriptase is a protein that converts RNA to deoxyribonucleic acid (DNA), reversing the usual direction of cellular transcription (DNA into RNA) Because of the operation of reverse transcriptase, genetic material from a retrovirus has the potential to become permanently integrated into the DNA genome of an infected cell. In the biological sciences, the enzyme is widely employed to combine genes. Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS) in humans. Simian immunodeficiency virus (SIV), a retrovirus prevalent in chimps and gorillas, is closely linked to HIV.
Related Conference of HIV and Retroviral Diseases
HIV and Retroviral Diseases Conference Speakers
Recommended Sessions
- AIDS stigma and discrimination
- Awareness and knowledge on HIV/AIDS, STDs and STIs
- Emerging Technologies towards HIV/AIDS
- HIV & Vaccines
- HIV and Aging
- HIV and AIDS Nursing Care Management
- HIV and bone damage
- HIV and cardiovascular disease
- HIV and Retroviral Diseases
- HIV Diagnosis and Therapy
- HIV Drug Discovery and Research
- HIV in women
- HIV/AIDS Nursing and AIDS awareness
- Lived experience of HIV
- Pediatric HIV AIDS
- Venereal Diseases Prevention and Treatment
- Viral Immunology and Vaccines development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advanced Brain Death Imaging Techniques - BRAIN DEATH 2024 (France)
- Advocacy for Improved Care - BRAIN DEATH 2024 (France)
- AI and Machine Learning in Diagnosis - BRAIN DEATH 2024 (France)
- Collaborative Models of Brain Death Care - BRAIN DEATH 2024 (France)
- Cultural Sensitivity in Care - BRAIN DEATH 2024 (France)
- Ethics in Brain Death Diagnosis - BRAIN DEATH 2024 (France)
- Family-Centered Care Strategies - BRAIN DEATH 2024 (France)
- Global Insights on Brain Death Care - BRAIN DEATH 2024 (France)
- Innovative Neurocritical Care Approaches - BRAIN DEATH 2024 (France)
- Legal Perspectives on Brain Death - BRAIN DEATH 2024 (France)
- Neuroethics: End-of-Life Decisions - BRAIN DEATH 2024 (France)
- Neuromonitoring Innovations - BRAIN DEATH 2024 (France)
- Neurorehabilitation for Survivors - BRAIN DEATH 2024 (France)
- Neuroscience Revolution: Latest Breakthroughs - BRAIN DEATH 2024 (France)
- Novel Therapies for Brain Death Patients - BRAIN DEATH 2024 (France)
- Organ Donation Challenges and Solutions - BRAIN DEATH 2024 (France)
- Palliative Care Strategies - BRAIN DEATH 2024 (France)
- Public Awareness Campaigns - BRAIN DEATH 2024 (France)
- Research Translation to Practice - BRAIN DEATH 2024 (France)
- Supporting Patients and Families - BRAIN DEATH 2024 (France)